These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 21131482

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium.
    Butler KL, Huffman LC, Koch SE, Hahn HS, Gwathmey JK.
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H797-803. PubMed ID: 16565302
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulating RISK: a role for JAK-STAT signaling in postconditioning?
    Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL.
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1649-56. PubMed ID: 18708442
    [Abstract] [Full Text] [Related]

  • 5. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning.
    Suleman N, Somers S, Smith R, Opie LH, Lecour SC.
    Cardiovasc Res; 2008 Jul 01; 79(1):127-33. PubMed ID: 18339648
    [Abstract] [Full Text] [Related]

  • 6. A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning.
    Vessey DA, Li L, Jin ZQ, Kelley M, Honbo N, Zhang J, Karliner JS.
    Oxid Med Cell Longev; 2011 Jul 01; 2011():961059. PubMed ID: 21904650
    [Abstract] [Full Text] [Related]

  • 7. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling.
    Zuurbier CJ, Jong WM, Eerbeek O, Koeman A, Pulskens WP, Butter LM, Leemans JC, Hollmann MW.
    PLoS One; 2012 Jul 01; 7(7):e40643. PubMed ID: 22848390
    [Abstract] [Full Text] [Related]

  • 8. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.
    Wang L, Quan N, Sun W, Chen X, Cates C, Rousselle T, Zhou X, Zhao X, Li J.
    Cardiovasc Res; 2018 May 01; 114(6):805-821. PubMed ID: 29409011
    [Abstract] [Full Text] [Related]

  • 9. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning.
    Lankford AR, Yang JN, Rose'Meyer R, French BA, Matherne GP, Fredholm BB, Yang Z.
    Am J Physiol Heart Circ Physiol; 2006 Apr 01; 290(4):H1469-73. PubMed ID: 16299262
    [Abstract] [Full Text] [Related]

  • 10. Role of STAT3 in ischemic preconditioning.
    Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK.
    J Mol Cell Cardiol; 2001 Nov 01; 33(11):1929-36. PubMed ID: 11708838
    [Abstract] [Full Text] [Related]

  • 11. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning.
    Yamaura G, Turoczi T, Yamamoto F, Siddqui MA, Maulik N, Das DK.
    Am J Physiol Heart Circ Physiol; 2003 Aug 01; 285(2):H476-82. PubMed ID: 12860560
    [Abstract] [Full Text] [Related]

  • 12. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
    Jin ZQ, Zhang J, Huang Y, Hoover HE, Vessey DA, Karliner JS.
    Cardiovasc Res; 2007 Oct 01; 76(1):41-50. PubMed ID: 17610857
    [Abstract] [Full Text] [Related]

  • 13. Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes.
    Morrison RR, Teng B, Oldenburg PJ, Katwa LC, Schnermann JB, Mustafa SJ.
    Am J Physiol Heart Circ Physiol; 2006 Oct 01; 291(4):H1875-82. PubMed ID: 16679400
    [Abstract] [Full Text] [Related]

  • 14. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A, Chen BD, Liu F, Chen XC, Gai MT, Li XM, Ma YT, Du XJ, Yang YN, Gao XM.
    Clin Sci (Lond); 2019 Mar 15; 133(5):665-680. PubMed ID: 30804219
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
    Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, Opie LH.
    Circulation; 2005 Dec 20; 112(25):3911-8. PubMed ID: 16344382
    [Abstract] [Full Text] [Related]

  • 16. Differences in prolonged ischemia length using ischemic preconditioning in the rabbit heart. Tolerable limitation time for surgically induced myocardial ischemia during normothermic cardiac operation.
    Uematsu M, Okada M.
    J Cardiovasc Surg (Torino); 2001 Jun 20; 42(3):323-31. PubMed ID: 11398027
    [Abstract] [Full Text] [Related]

  • 17. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
    Zhu B, Min S, Long C, Ye T.
    Chin Med J (Engl); 2003 Feb 20; 116(2):253-7. PubMed ID: 12775242
    [Abstract] [Full Text] [Related]

  • 18. Ischemic preconditioning depends on age and gender.
    Turcato S, Turnbull L, Wang GY, Honbo N, Simpson PC, Karliner JS, Baker AJ.
    Basic Res Cardiol; 2006 May 20; 101(3):235-43. PubMed ID: 16450074
    [Abstract] [Full Text] [Related]

  • 19. lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3.
    Gent S, Skyschally A, Kleinbongard P, Heusch G.
    Am J Physiol Heart Circ Physiol; 2017 Mar 01; 312(3):H478-H484. PubMed ID: 28039203
    [Abstract] [Full Text] [Related]

  • 20. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning.
    Smith RM, Suleman N, Lacerda L, Opie LH, Akira S, Chien KR, Sack MN.
    Cardiovasc Res; 2004 Sep 01; 63(4):611-6. PubMed ID: 15306216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.